These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21712096)

  • 1. Effect of oxybutynin and imidafenacin on central muscarinic receptor occupancy and cognitive function: a monkey PET study with [(11)C](+)3-MPB.
    Yamamoto S; Maruyama S; Ito Y; Kawamata M; Nishiyama S; Ohba H; Yamada S; Tsukada H
    Neuroimage; 2011 Sep; 58(1):1-9. PubMed ID: 21712096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive evaluation of brain muscarinic receptor occupancy of oxybutynin, darifenacin and imidafenacin in rats by positron emission tomography.
    Yoshida A; Maruyama S; Fukumoto D; Tsukada H; Ito Y; Yamada S
    Life Sci; 2010 Jul; 87(5-6):175-80. PubMed ID: 20598326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic receptor occupancy and cognitive impairment: a PET study with [11C](+)3-MPB and scopolamine in conscious monkeys.
    Yamamoto S; Nishiyama S; Kawamata M; Ohba H; Wakuda T; Takei N; Tsukada H; Domino EF
    Neuropsychopharmacology; 2011 Jun; 36(7):1455-65. PubMed ID: 21430646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo quantitative autoradiographic analysis of brain muscarinic receptor occupancy by antimuscarinic agents for overactive bladder treatment.
    Maruyama S; Tsukada H; Nishiyama S; Kakiuchi T; Fukumoto D; Oku N; Yamada S
    J Pharmacol Exp Ther; 2008 Jun; 325(3):774-81. PubMed ID: 18326811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective binding of bladder muscarinic receptors in relation to the pharmacokinetics of a novel antimuscarinic agent, imidafenacin, to treat overactive bladder.
    Yamada S; Seki M; Ogoda M; Fukata A; Nakamura M; Ito Y
    J Pharmacol Exp Ther; 2011 Feb; 336(2):365-71. PubMed ID: 21047953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: bladder selectivity based on in vivo drug-receptor binding characteristics of antimuscarinic agents for treatment of overactive bladder.
    Yoshida A; Fujino T; Maruyama S; Ito Y; Taki Y; Yamada S
    J Pharmacol Sci; 2010; 112(2):142-50. PubMed ID: 20134113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of reference tissue model of PET ligand [¹¹C]+3-MPB for the muscarinic cholinergic receptor in the living brain of conscious monkey.
    Yamamoto S; Ohba H; Nishiyama S; Takahashi K; Tsukada H
    Synapse; 2011 Jun; 65(6):548-51. PubMed ID: 21064187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of novel PET ligands (+)N-[11C]methyl-3-piperidyl benzilate ([11C](+)3-MPB) and its stereoisomer [11C](-)3-MPB for muscarinic cholinergic receptors in the conscious monkey brain: a PET study in comparison with.
    Tsukada H; Takahashi K; Miura S; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Hatazawa J; Okudera T
    Synapse; 2001 Feb; 39(2):182-92. PubMed ID: 11180506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of PET ligands (+)N-[(11)C]ethyl-3-piperidyl benzilate and (+)N-[(11)C]propyl-3-piperidyl benzilate for muscarinic cholinergic receptors: a PET study with microdialysis in comparison with (+)N-[(11)C]methyl-3-piperidyl benzilate in the conscious monkey brain.
    Nishiyama S; Tsukada H; Sato K; Kakiuchi T; Ohba H; Harada N; Takahashi K
    Synapse; 2001 Jun; 40(3):159-69. PubMed ID: 11304753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological effects of imidafenacin (KRP-197/ONO-8025), a new bladder selective anti-cholinergic agent, in rats. Comparison of effects on urinary bladder capacity and contraction, salivary secretion and performance in the Morris water maze task.
    Kobayashi F; Yageta Y; Yamazaki T; Wakabayashi E; Inoue M; Segawa M; Matsuzawa S
    Arzneimittelforschung; 2007; 57(3):147-54. PubMed ID: 17469649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imidafenacin has no influence on learning in nucleus basalis of Meynert-lesioned rats.
    Yamazaki T; Fukata A
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Dec; 386(12):1095-102. PubMed ID: 23995257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of bladder selectivity of antimuscarinic agents on the basis of in vivo drug-receptor binding.
    Yamada S; Kuraoka S; Osano A; Ito Y
    Int Neurourol J; 2012 Sep; 16(3):107-15. PubMed ID: 23094215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary Excretion Contributes to Long-Lasting Blockade of Bladder Muscarinic Receptors by Imidafenacin: Effect of Bilateral Ureteral Ligation.
    Ito Y; Kuraoka S; Endo S; Takahashi A; Onoue S; Yamada S
    J Pharmacol Exp Ther; 2017 Jan; 360(1):69-74. PubMed ID: 27831487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related changes in muscarinic cholinergic receptors in the living brain: a PET study using N-[11C]methyl-4-piperidyl benzilate combined with cerebral blood flow measurement in conscious monkeys.
    Kakiuchi T; Ohba H; Nishiyama S; Sato K; Harada N; Nakanishi S; Tsukada H
    Brain Res; 2001 Oct; 916(1-2):22-31. PubMed ID: 11597587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of muscarinic receptor binding and inhibition of salivation after oral administration of tolterodine in mice.
    Oki T; Maruyama S; Takagi Y; Yamamura HI; Yamada S
    Eur J Pharmacol; 2006 Jan; 529(1-3):157-63. PubMed ID: 16316647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in mice.
    Oki T; Sato S; Miyata K; Yamada S
    Br J Pharmacol; 2005 May; 145(2):219-27. PubMed ID: 15753946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urodynamic effects of oxybutynin and tolterodine in conscious and anesthetized rats under different cystometrographic conditions.
    Angelico P; Velasco C; Guarneri L; Sironi G; Leonardi A; Testa R
    BMC Pharmacol; 2005 Oct; 5():14. PubMed ID: 16216132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways.
    Kim Y; Yoshimura N; Masuda H; de Miguel F; Chancellor MB
    Urology; 2005 Feb; 65(2):238-42. PubMed ID: 15708029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age differences in muscarinic cholinergic receptors assayed with (+)N-[(11)C]methyl-3-piperidyl benzilate in the brains of conscious monkeys.
    Tsukada H; Kakiuchi T; Nishiyama S; Ohba H; Sato K; Harada N; Takahashi K
    Synapse; 2001 Sep; 41(3):248-57. PubMed ID: 11418938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic receptor occupancy by biperiden in living human brain.
    Sudo Y; Suhara T; Suzuki K; Okubo Y; Yoshikawa K; Uchida S; Sassa T; Okauchi T; Sasaki Y; Matsushita M
    Life Sci; 1999; 64(8):PL99-104. PubMed ID: 10069534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.